Is there an ideal stimulation regimen for IVF for poor responders and does it change with age?

Journal of Assisted Reproduction and Genetics

Volumn 25, Issue 11-12, 2008, Pages 523-529

  Vollenhoven, Beverley ^a,b,c   Osianlis, Tiki ^c   Catt, James ^c  

^a MONASH UNIVERSITY   (Australia)

^b Southern Health ^*  (Australia)

^c MONASH IVF   (Australia)

Author keywords

IVF success; Poor responder; Stimulation regimen

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; GONADORELIN ANTAGONIST; NAFARELIN ACETATE; PROGESTERONE; PROGESTERONE PESSARIES; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY CYCLE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; MALE; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 57349184555     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-008-9274-6     Document Type: Article

References (32)

1. JE Garcia GS Jones AA Acosta G Wright 1983 HMG/HCG follicular maturation for oocytes aspiration: phase II, 1981 Fertil Steril. 39 174 1791
2. SD Keay NH Liversedge RS Mathur JM Jemkins 1997 Assisted conception following poor ovarian response to gonadotrophin stimulation Br J Obstet Gynaecol. 104 521 7
3. FI Sharara SN Beatse MR Leonard D Navot RT Scott 1994 Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by clomiphene citrate challenge test Fertil Steril. 62 257 62
4. RJ Stillman MJ Rosenberg BP Sachs 1986 Smoking and reproduction Fertil Steril. 46 545 66
5. D Nikolaou A Templeton 2003 Early ovarian ageing: A hypothesis. Detection and clinical relevance. Hum Reprod. 18 1137 1139
6. th Edition. Baltimore, MD: Lippincott Williams and Wilkins, 19995. Nikolaou D, Templeton A: Early ovarian ageing: A hypothesis. Detection and clinical relevance Hum Reprod 18 1137 9
7. DW Lee P Grasso B Dattatreyamurty MR Deziel LE Reichert Jr 1993 Purification of a high molecular weight FSH-receptor binding inhibitor, from human follicular fluid J Clin Endocrinol Metab 77 160 8
8. AJ Zeleznik HM Schuler LE Reichter 1981 Gonatotrophin binding sites in the rhesus monkey ovary; role of the vasculature in the selective distribution of HCG to the preovulatory follicle Endocrinology. 109 356 62
9. ER Hernandez A Hurwitz A Vera A Pellicer EY Adashi D LeRoith 1992 Expression of the genes encoding the IGFs and their receptors in the human ovary J Clin Endocrinol Metab 74 419 25
10. RT Scott GE Hofmann S Oehninger SJ. Muasher 1990 Intercycle variability of day 3 follicle-stimulating hormone concentrations and its effect on stimulation quality in in-vitro fertilization. Fertility &. Sterility 54 297 302
11. RT Scott GE Hofmann 1995 Prognostic assessment of ovarian reserve Fertil Steril. 63 1 11
12. DB Seifer G Lambert-Mersserlian J Hogan AC Gardiner AS Blazar 1997 Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome Fertil Steril. 67 110 4
13. DB Seifer DT Maclaughlin 2007 Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance Fertil Steril. 88 539 46
14. IAJ Van Rooij FJM Broekmans ER te Velde BCJM Fauser LFJMM Bancsi FH de jong 2002 Serum antimullerian hormone levels: a novel measure of ovarian reserve Hum Reprod. 17 3065 71
15. JG Franco Jr RL Baruffi AL Mauri 2006 GnRH agonist versus GnRH antagonist in poor responders: a meta analysis Reprod Biomed Online. 13 618 27
16. G Griesinger K Diedrich BC Tarlatzis EM Kolibianakis 2006 GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: A meta analysis Reprod Biomed Online. 13 628 38
17. NG Mahutte A Arici 2007 Role of gonadotropin-releasing hormone antagonists in poor responders Fertil Steril. 87 241 9
18. S Shanbhag L Aucott S Bhattacharya MA Hamilton AR McTavish 2007 Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF) Cochrane Database Syst Rev Issue 1 CD004379
19. Tarlatzis BC, Kirou D, Venetis CA. Management of poor response: Facts or myths In Advances in Fertility Studies and Reproductive Medicine, IFFS 2007 In: Kruger TF, Van Der Spuy Z, Kempers RD editors. Juta & Co Ltd; 2007. p. 311-318.
20. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in an in vitro fertilization and gamete intrafallopian transfer cycles (Cochrane Review). In: The Cochrane Library, Issue 1, 2000. Oxford: Update Software.
21. MA Akman HF Erden SB Tosun N Bayazitet E Aksoy M Bahceci 2001 Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial Hum Reprod. 16 868 70
22. LP Cheung PM Lam IH Lok 2005 GnRH antagonist versus long GnRH agonist protocols in poor responders undergoing IVF: a randomized controlled trial Hum Reprod. 20 616 21
23. ES Surrey WB Schoolcraft 2000 Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques Fertil Steril. 73 667 76
24. ER Klinkert FJ Broekmans CW Bllman ER Te Venlde 2004 A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles Fertil Steril 81 1247 53
25. A Weissman J Farhi M Royburt 2003 Prospective evaluation of 2 stimulation protocols for low responders who were undergoing in-vitro fertilization-embryo transfer Fertil Steril. 79 886 92
26. M Dirnfield Y Gonen A Lissak S Goldman M Koifman Y Sorokin 1991 A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in-vitro fertilization (IVF) cycles due to inadequate ovarian response J In Vitro Fert Embryo Transf. 8 339 43
27. KA Mohamed WA Davies J Allsopp H Lashen 2005 Agonist "flare-up" versus antagonist in the management of poor responders undergoing in vitro fertilization treatment Fertil Steril. 84 331 5
28. M Dirnfield O Fruchter D Yshai 1999 Cessation of gonadotrophin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH: A protocol in poor responders undergoing in vitro-fertilization Fertil Steril. 72 406 11
29. JA Garcia-Velasco V Isaza A Requena 2000 High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients; a prospective, randomized, controlled trial Hum Reprod. 15 2292 6
30. MA Akman HF Erden SB Tosun N Bayazit E Aksoy M Bahceci 2000 Addition of GnRH antagonist in cycles of poor responders undergoing IVF Hum Reprod. 15 2145 7
31. F Morgia M Sbracia M Schimberni 2004 A controlled trial of natural cycle versus microdose gonadotrophin-releasing hormone analog flare cycles in poor responders undergoing in-vitro fertilization Fertil Steril. 81 1542 7
32. K Bendikson AA Milki A Speck-Zulak LM Westphal 2006 Comparison of GnRH antagonist cycles with or without oral contraceptive pre-treatment in potential poor prognosis patients Clin Exp Obstet Gynecol. 33 145 7